• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新西兰药物的使用起始情况及终生使用情况:来自《蒂罗·希内加罗:2003 - 2004年新西兰心理健康调查》的结果

Onset and lifetime use of drugs in New Zealand: results from Te Rau Hinengaro: the New Zealand Mental Health Survey 2003-2004.

作者信息

Wells Jessie Elisabeth, McGee Magnus A, Baxter Joanne, Agnew Francis, Kokaua Jesse

机构信息

Department of Public Health and General Practice, University of Otago, Christchurch, New Zealand.

出版信息

Drug Alcohol Rev. 2009 Mar;28(2):166-74. doi: 10.1111/j.1465-3362.2008.00043.x.

DOI:10.1111/j.1465-3362.2008.00043.x
PMID:19320702
Abstract

INTRODUCTION AND AIMS

Onset and lifetime use of drugs have not previously been reported for all adult ages in New Zealand. This paper reports such results and, for people born in New Zealand, compares age of onset across ethnic groups.

DESIGN AND METHODS

A nationally representative cross-sectional survey was carried out in 2003-2004, with oversampling of Māori and Pacific people. Participants were aged 16 years or more, living in permanent private dwellings. In the Composite International Diagnostic Interview (CIDI 3.0), participants were asked if they had ever used drugs (alcohol, tobacco and five groups of other drugs) and the age of first use (except for tobacco). Estimates are weighted.

RESULTS

The response rate of 73.3% yielded 12 992 interviews. The percentage of participants who had ever used drugs was: 94.6% for alcohol, 50.8% for tobacco and 42.6% for any extramedical drug, including 41.6% for cannabis, 4.2% for cocaine and 2.9% for opioids. Use was much more common in recent cohorts for extramedical drugs. The median age of onset in each age cohort was always lowest for alcohol, then cannabis, then opioids, then cocaine. Among those born in New Zealand, Māori were more at risk of use than 'Others' with the lowest risk for Pacific people.

DISCUSSION AND CONCLUSIONS

Interventions to prevent or to delay the onset of drug use need to occur before and during adolescence. The major cohort differences and the widespread experience of cannabis use help to explain the diversity of opinion in New Zealand about how to deal with this drug.

摘要

引言与目的

此前尚未有关于新西兰所有成年年龄段药物使用起始情况和终生使用情况的报告。本文报告了此类结果,并针对出生在新西兰的人群,比较了不同种族群体的药物使用起始年龄。

设计与方法

2003年至2004年开展了一项具有全国代表性的横断面调查,对毛利人和太平洋岛民进行了过度抽样。参与者年龄在16岁及以上,居住在永久性私人住宅中。在综合国际诊断访谈(CIDI 3.0)中,询问参与者是否曾使用过药物(酒精、烟草和其他五类药物)以及首次使用的年龄(烟草除外)。估计值经过加权处理。

结果

73.3%的回复率产生了12992份访谈。曾使用过药物的参与者百分比分别为:酒精94.6%、烟草50.8%、任何非医疗用途药物42.6%,其中大麻41.6%、可卡因4.2%、阿片类药物2.9%。非医疗用途药物在最近几代人群中使用更为普遍。每个年龄组的药物使用起始年龄中位数始终是酒精最低,其次是大麻,然后是阿片类药物,最后是可卡因。在出生于新西兰的人群中,毛利人比“其他种族”有更高的药物使用风险,太平洋岛民风险最低。

讨论与结论

预防或延迟药物使用起始的干预措施需要在青春期之前和期间实施。主要的代际差异以及大麻使用的广泛情况有助于解释新西兰在如何处理这种药物问题上存在的意见分歧。

相似文献

1
Onset and lifetime use of drugs in New Zealand: results from Te Rau Hinengaro: the New Zealand Mental Health Survey 2003-2004.新西兰药物的使用起始情况及终生使用情况:来自《蒂罗·希内加罗:2003 - 2004年新西兰心理健康调查》的结果
Drug Alcohol Rev. 2009 Mar;28(2):166-74. doi: 10.1111/j.1465-3362.2008.00043.x.
2
Ethnic comparisons of the 12 month prevalence of mental disorders and treatment contact in Te Rau Hinengaro: the New Zealand Mental Health Survey.《特劳希内加罗:新西兰心理健康调查中精神障碍12个月患病率及治疗接触情况的种族比较》
Aust N Z J Psychiatry. 2006 Oct;40(10):905-13. doi: 10.1080/j.1440-1614.2006.01910.x.
3
Twelve-month and lifetime prevalences of mental disorders and treatment contact among Pacific people in Te Rau Hinengaro: the New Zealand Mental Health Survey.《特劳希内加罗:新西兰心理健康调查》中太平洋人群精神障碍的12个月患病率和终生患病率以及治疗接触情况
Aust N Z J Psychiatry. 2006 Oct;40(10):924-34. doi: 10.1080/j.1440-1614.2006.01912.x.
4
Prevalence of mental disorders among Māori in Te Rau Hinengaro: the New Zealand Mental Health Survey.《特劳希内加罗(Te Rau Hinengaro)中毛利人的精神障碍患病率:新西兰心理健康调查》
Aust N Z J Psychiatry. 2006 Oct;40(10):914-23. doi: 10.1080/j.1440-1614.2006.01911.x.
5
Lifetime prevalence and projected lifetime risk of DSM-IV disorders in Te Rau Hinengaro: the New Zealand Mental Health Survey.《特劳希内加罗地区精神疾病诊断与统计手册第四版(DSM-IV)障碍的终生患病率及终生患病风险预测:新西兰心理健康调查》
Aust N Z J Psychiatry. 2006 Oct;40(10):865-74. doi: 10.1080/j.1440-1614.2006.01905.x.
6
Twelve-month prevalence, severity, and treatment contact of mental disorders in New Zealand born and migrant Pacific participants in Te Rau Hinengaro: The New Zealand Mental Health Survey.《特劳希内加罗:新西兰心理健康调查》中新西兰出生及移民的太平洋岛民参与者的精神障碍12个月患病率、严重程度及治疗接触情况
Pac Health Dialog. 2009 Feb;15(1):9-17.
7
Suicidal behaviour in Te Rau Hinengaro: the New Zealand Mental Health Survey.《特劳希内加罗的自杀行为:新西兰心理健康调查》
Aust N Z J Psychiatry. 2006 Oct;40(10):896-904. doi: 10.1080/j.1440-1614.2006.01909.x.
8
Twelve-month and lifetime health service use in Te Rau Hinengaro: The New Zealand Mental Health Survey.《特劳希内加罗的十二个月及终生医疗服务使用情况:新西兰心理健康调查》
Aust N Z J Psychiatry. 2006 Oct;40(10):855-64. doi: 10.1080/j.1440-1614.2006.01904.x.
9
Te Rau Hinengaro: the New Zealand Mental Health Survey: overview of methods and findings.《蒂劳·希内加罗:新西兰心理健康调查》:方法与结果概述
Aust N Z J Psychiatry. 2006 Oct;40(10):835-44. doi: 10.1080/j.1440-1614.2006.01902.x.
10
The Kessler Psychological Distress Scale in Te Rau Hinengaro: the New Zealand Mental Health Survey.《特劳亨宁加罗心理健康困扰量表:新西兰心理健康调查》。
Aust N Z J Psychiatry. 2010 Apr;44(4):314-22. doi: 10.3109/00048670903279820.

引用本文的文献

1
Perceived risk of LSD varies with age and race: evidence from 2019 United States cross-sectional data.人们对 LSD 的感知风险因年龄和种族而异:来自 2019 年美国横断面数据的证据。
Soc Psychiatry Psychiatr Epidemiol. 2023 Oct;58(10):1503-1508. doi: 10.1007/s00127-023-02448-6. Epub 2023 Mar 6.
2
Baseline brain and behavioral factors distinguish adolescent substance initiators and non-initiators at follow-up.基线脑和行为因素在随访时可区分青少年物质使用者和未使用者。
Front Psychiatry. 2022 Dec 8;13:1025259. doi: 10.3389/fpsyt.2022.1025259. eCollection 2022.
3
The adolescent brain at risk for substance use disorders: a review of functional MRI research on motor response inhibition.
面临物质使用障碍风险的青少年大脑:关于运动反应抑制的功能磁共振成像研究综述
Curr Opin Behav Sci. 2017 Feb;13:186-195. doi: 10.1016/j.cobeha.2016.12.006. Epub 2017 Jan 10.
4
Cross-national comparisons of sex differences in opportunities to use alcohol or drugs, and the transitions to use.跨国比较使用酒精或毒品的机会方面的性别差异,以及使用这些物质的转变。
Subst Use Misuse. 2011;46(9):1169-78. doi: 10.3109/10826084.2011.553659. Epub 2011 Mar 21.
5
Violations of the usual sequence of drug initiation: prevalence and associations with the development of dependence in the New Zealand Mental Health Survey.违反常规药物起始顺序的情况:新西兰心理健康调查中的患病率及其与成瘾发展的关联。
J Stud Alcohol Drugs. 2008 Nov;69(6):789-95. doi: 10.15288/jsad.2008.69.789.